Premium
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-27 | Mr. Alan B. MillerFounder & Executive Chairman of the Board | -177,27k | 0,00 | Other Disposition | - | 2,20M | -7,46% |
| 2026-03-19 | Mr. Edward H. SimExec. VP & President of Acute Care Division | -1,30k | 243,66k | Sale to Issuer | 185,82 - 189,58 | 10,86k | -10,67% |
| 2026-03-19 | Mr. Matthew Jay PetersonInitié | -1,12k | 210,40k | Sale to Issuer | 185,82 - 189,58 | 19,74k | -5,37% |
| 2026-03-19 | Mr. Steve G. FiltonExec. VP, CFO & Secretary | -1,35k | 253,05k | Sale to Issuer | 185,82 - 189,58 | 290,81k | -0,46% |
| 2026-03-19 | Mr. Marc D. MillerCEO, President & Director | -5,00k | 939,67k | Sale to Issuer | 185,82 - 189,58 | 326,47k | -1,51% |
| 2026-03-19 | Mr. Alan B. MillerFounder & Executive Chairman of the Board | -2,58k | 483,93k | Sale to Issuer | 185,82 - 189,58 | 2,20M | -0,12% |
| 2026-03-12 | Ms. Maria Ruderman SingerIndependent Director | 691,00 | 95,91k | Derivative Exercise and Retained Stock | 138,80 | 7,51k | 10,13% |
| 2026-03-12 | Ms. Maria Ruderman SingerIndependent Director | -1,81k | 96,01k | Derivative Exercise and Sale | 138,80 - 191,88 | 7,51k | - |
| 2026-03-12 | Mr. Matthew Jay PetersonInitié | -5,67k | 1,08M | Sale to Issuer | 190,49 | 18,26k | -23,69% |
| 2026-03-12 | Mr. Edward H. SimExec. VP & President of Acute Care Division | -6,56k | 1,25M | Sale to Issuer | 190,49 | 9,19k | -41,66% |
| 2026-03-12 | Mr. Alan B. MillerFounder & Executive Chairman of the Board | -13,05k | 2,48M | Sale to Issuer | 190,49 | 2,19M | -0,59% |
| 2026-03-12 | Mr. Marc D. MillerCEO, President & Director | 14,38k | 2,00M | Derivative Exercise and Retained Stock | 138,80 | 318,76k | 4,72% |
| 2026-03-12 | Mr. Marc D. MillerCEO, President & Director | -86,05k | 3,78M | Derivative Exercise and Sale | 138,80 - 190,83 | 318,76k | - |
| 2026-03-12 | Mr. Marc D. MillerCEO, President & Director | -24,81k | 4,73M | Sale to Issuer | 190,49 | 318,76k | -7,22% |
| 2026-03-12 | Mr. Steve G. FiltonExec. VP, CFO & Secretary | 11,49k | 1,59M | Derivative Exercise and Retained Stock | 138,80 | 288,99k | 4,14% |
| 2026-03-12 | Mr. Steve G. FiltonExec. VP, CFO & Secretary | -71,75k | 3,23M | Derivative Exercise and Sale | 138,80 - 192,28 | 288,99k | - |
| 2026-03-12 | Mr. Steve G. FiltonExec. VP, CFO & Secretary | -6,82k | 1,30M | Sale to Issuer | 190,49 | 288,99k | -2,30% |
| 2026-03-11 | Dr. Elliot J. SussmanIndependent Director | -2,50k | 128,39k | Derivative Exercise and Sale | 138,80 - 194,27 | 5,05k | - |
| 2026-03-10 | Mr. Alan B. MillerFounder & Executive Chairman of the Board | 18,45k | 2,56M | Derivative Exercise and Retained Stock | 138,80 | 2,17M | 0,86% |
| 2026-03-10 | Mr. Alan B. MillerFounder & Executive Chairman of the Board | -114,26k | 4,83M | Derivative Exercise and Sale | 138,80 - 189,62 | 2,17M | - |
| 2025-11-11 | Mr. Warren J. NimetzDirector | -10,00k | 852,36k | Derivative Exercise and Sale | 138,80 - 224,49 | 7,42k | - |
| 2025-10-29 | Mr. Matthew Jay PetersonInitié | 3,58k | 496,63k | Derivative Exercise and Retained Stock | 138,80 | 10,74k | 49,97% |
| 2025-10-29 | Mr. Matthew Jay PetersonInitié | -14,31k | 1,10M | Derivative Exercise and Sale | 138,80 - 225,15 | 10,74k | - |
| 2025-10-29 | Dr. Elliot J. SussmanIndependent Director | -2,50k | 217,94k | Derivative Exercise and Sale | 138,80 - 226,15 | 5,05k | - |
| 2025-10-29 | Mr. Alan B. MillerFounder & Executive Chairman of the Board | 27,19k | 4,15M | Derivative Exercise and Retained Stock | 152,68 | 2,16M | 1,28% |
| 2025-10-29 | Mr. Alan B. MillerFounder & Executive Chairman of the Board | -105,52k | 8,71M | Derivative Exercise and Sale | 138,80 - 227,04 | 2,16M | - |
| 2025-10-29 | Mr. Marc D. MillerCEO, President & Director | 33,24k | 4,61M | Derivative Exercise and Retained Stock | 138,80 | 266,15k | 14,27% |
| 2025-10-29 | Mr. Marc D. MillerCEO, President & Director | -131,76k | 10,15M | Derivative Exercise and Sale | 138,80 - 225,30 | 266,15k | - |
| 2025-08-05 | Mr. Alan B. MillerFounder & Executive Chairman of the Board | -350,00k | 0,00 | Other Disposition | - | 5,11M | -6,41% |
| 2025-08-06 | Mr. Alan B. MillerFounder & Executive Chairman of the Board | -400,00k | 0,00 | Other Disposition | - | 1,98M | -16,80% |
| 2025-08-05 | Mr. Marc D. MillerCEO, President & Director | -354,80k | 0,00 | Other Disposition | - | 0,00 | -100,00% |
| 2025-08-05 | Mr. Marc D. MillerCEO, President & Director | -350,00k | 0,00 | Other Derivative Disposition | - | 0,00 | -100,00% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
